369 related articles for article (PubMed ID: 33885724)
41. Demographic Disparities in the Federal Drug Approval Process for Allergic Rhinitis Medications.
Liebowitz A; Spielman DB; Schlosser RJ; Stewart MG; Gudis DA
Laryngoscope; 2023 Apr; 133(4):755-763. PubMed ID: 35394648
[TBL] [Abstract][Full Text] [Related]
42. Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers.
Morgan A; Shah K; Tran K; Chino F
JAMA Netw Open; 2021 Jun; 4(6):e2112807. PubMed ID: 34097046
[TBL] [Abstract][Full Text] [Related]
43. Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials.
Kanapuru B; Fernandes LL; Fashoyin-Aje LA; Baines AC; Bhatnagar V; Ershler R; Gwise T; Kluetz P; Pazdur R; Pulte E; Shen YL; Gormley N
Blood Adv; 2022 Mar; 6(6):1684-1691. PubMed ID: 35114691
[TBL] [Abstract][Full Text] [Related]
44. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019.
Dhodapkar M; Zhang AD; Puthumana J; Downing NS; Shah ND; Ross JS
JAMA Netw Open; 2021 Jun; 4(6):e2113224. PubMed ID: 34110392
[TBL] [Abstract][Full Text] [Related]
46. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.
Raman R; Quiroz YT; Langford O; Choi J; Ritchie M; Baumgartner M; Rentz D; Aggarwal NT; Aisen P; Sperling R; Grill JD
JAMA Netw Open; 2021 Jul; 4(7):e2114364. PubMed ID: 34228129
[TBL] [Abstract][Full Text] [Related]
47. Lack of racial and ethnic diversity in pediatric ophthalmology clinical trials from 2000 to 2022.
Kuo A; Yazji I; Abbass N; Chong DD; Fane L; Örge FH
J AAPOS; 2024 Apr; 28(2):103870. PubMed ID: 38460595
[TBL] [Abstract][Full Text] [Related]
48. Diversity in Orthopaedic Surgery Medical Device Clinical Trials: An Analysis of the Food and Drug Administration Safety and Innovation Act.
Issa TZ; Lambrechts MJ; Lin JS; Brush PL; Canseco JA; Hilibrand AS; Kepler CK; Schroeder GD; Vaccaro AR
J Am Acad Orthop Surg; 2023 Feb; 31(3):155-165. PubMed ID: 36525566
[TBL] [Abstract][Full Text] [Related]
49. Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.
Vergroesen JE; Thee EF; Ahmadizar F; van Duijn CM; Stricker BH; Kavousi M; Klaver CCW; Ramdas WD
JAMA Ophthalmol; 2022 Jul; 140(7):674-681. PubMed ID: 35587864
[TBL] [Abstract][Full Text] [Related]
50. Improved clinical trial race/ethnicity reporting and updated inclusion profile, 2017-2022: A New Jersey snapshot.
Paleoudis EG; Han Z; Gelman S; Arias-Ruiz H; Carter D; Bertrand J; Mastrogiovanni N; Terlecky SR
Glob Epidemiol; 2024 Jun; 7():100134. PubMed ID: 38259323
[TBL] [Abstract][Full Text] [Related]
51. Race and Ethnicity Reporting and Representation in Obstetrics and Gynecology Clinical Trials and Publications From 2007-2020.
Steinberg JR; Turner BE; DiTosto JD; Weeks BT; Young AMP; Lu CF; Wolgemuth T; Holder K; Laasiri N; Squires N; Zhang N; Richardson MT; Magnani CJ; Anderson JN; Roque DR; Yee LM
JAMA Surg; 2023 Feb; 158(2):181-190. PubMed ID: 36542396
[TBL] [Abstract][Full Text] [Related]
52. Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies.
Garg T; Gong AJ; Khalil A; Gowda PC; Weinstein RM; Holly BP; Weiss CR
J Vasc Interv Radiol; 2023 Jan; 34(1):4-10.e3. PubMed ID: 36167300
[TBL] [Abstract][Full Text] [Related]
53. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.
Richardson MT; Barry D; Steinberg JR; Thirunavu V; Strom DE; Holder K; Zhang N; Turner BE; Magnani CJ; Weeks BT; Young AMP; Lu CF; Wolgemuth TR; Laasiri N; Squires NA; Anderson JN; Karlan BY; Chan JK; Kapp DS; Roque DR; Salani R
Gynecol Oncol; 2024 Feb; 181():1-7. PubMed ID: 38096673
[TBL] [Abstract][Full Text] [Related]
54. Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot.
Matthew-Onabanjo AN; Nortey G; Matulewicz RS; Basak R; Culton DA; Weaver KN; Gallagher KK; Tan HJ; Rose TL; Milowsky M; Bjurlin MA
Curr Probl Cancer; 2023 Jun; 47(3):100958. PubMed ID: 37084464
[TBL] [Abstract][Full Text] [Related]
55. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
Lolic M; Araojo R; Okeke M; Temple R
J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
[TBL] [Abstract][Full Text] [Related]
56. Association of Race and Ethnicity With Late-Life Depression Severity, Symptom Burden, and Care.
Vyas CM; Donneyong M; Mischoulon D; Chang G; Gibson H; Cook NR; Manson JE; Reynolds CF; Okereke OI
JAMA Netw Open; 2020 Mar; 3(3):e201606. PubMed ID: 32215634
[TBL] [Abstract][Full Text] [Related]
57. Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug Administration.
Hilal T; Sonbol MB; Prasad V
JAMA Oncol; 2019 Jun; 5(6):887-892. PubMed ID: 31046071
[TBL] [Abstract][Full Text] [Related]
58. Racial and Ethnic Disparities in the Research and Care of Hereditary Angioedema Patients in the United States.
Sylvestre S; Craig T; Ajewole O; Craig S; Kaur S; Al-Shaikhly T
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4441-4449.e2. PubMed ID: 34464751
[TBL] [Abstract][Full Text] [Related]
59. Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies.
Mendis S; Anand S; Karasinska JM; Dasari A; Unger JM; Gothwal A; Ellis LM; Varadhachary G; Kopetz S; Overman MJ; Raghav K; Loree JM
Oncologist; 2021 Feb; 26(2):107-114. PubMed ID: 32960478
[TBL] [Abstract][Full Text] [Related]
60. Race and ethnicity reporting and representation in hemophilia clinical trials.
Fedewa SA; Valentino LA; Koo A; Cafuir L; Tran DQ; Antun A; Kempton CL
Blood Adv; 2024 May; 8(10):2351-2360. PubMed ID: 38547444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
